BioHorizons Seeking SFDA Approval of Dental Implant Products
July 22, 2010 at 14:29 PM EDT
In its initial filing for a Nasdaq IPO, BioHorizons, a US-based dental implant company, revealed it expects to market its products in China soon. The company has already submitted filings with the SFDA for approval of the medical devices. BioHorizon hopes its Nasdaq IPO will raise as much as $100 million. More details...
